Evoqua Water Technologies Corp. (NYSE:AQUA) Q1 2023 Earnings Call Transcript

Evoqua Water Technologies Corp. (NYSE:AQUA) Q1 2023 Earnings Call Transcript January 31, 2023

Operator: Hello and welcome to the Evoqua Water Technologies First Quarter Fiscal 2023 Earnings Conference Call. As a reminder, this conference call is being recorded and your participation implies consent to our recording of this call. If you do not agree with these terms, please disconnect at this time. Thank you. I would now like to turn the call over to Dan Brailer, Vice President of Investor Relations. Please go ahead.

Dan Brailer: Thank you, Todd. Thanks everyone for joining us for today’s call to review our first quarter 2023 financial results. Participating on today’s call are Ron Keating, President and Chief Executive Officer; and Ben Stas, Executive Vice President and Chief Financial Officer. After our prepared remarks, we will open the call to questions. This conference call includes forward-looking statements, including our full fiscal year 2023 expectations, long-term financial targets, statements relating to our pending merger with Xylem, statements relating to demand outlook in our end markets, growth opportunities, our order pipeline, order conversion, cash generation, our acquisition strategy and pipeline, integration and performance €“ future performance of our recent acquisitions, supply chain challenges, inflation, labor shortages and general macroeconomic conditions.

Actual results may differ materially from our expectations. For additional information on Evoqua, please refer to the company’s SEC filings, including the risk factors described therein. On this conference call, we will also discuss certain non-GAAP financial measures. Information with respect to such non-GAAP financial measures is included in the appendix of the presentation slides for this call, which can be obtained at Evoqua’s Investor Relations website. Unless otherwise specified, references on this call to full year measures or to a year refer to our fiscal year, which ends on September 30. Means to access this conference call via webcast were disclosed in the press release, which was posted on our Investor Relations website. Replays of this conference call will be archived and available for the next 60 days.

With that, I would now like to turn the call over to Ron. Ron?

Ron Keating: Thank you, Dan and thank you for joining us. Before we present our results, I am once again pleased to announce that on January 23, we entered into a definitive agreement for Xylem to acquire Evoqua in an all-stock transaction at a 30% premium to our closing price on the Friday before signing. Joining forces with Xylem is an exciting development for the market and an exciting opportunity for our team members. The combination provides a platform to leverage our combined strengths and we look forward to increasing our collective impact as we address increasingly complex global water challenges. As a company, we remain focused on executing our plan until the deal closes. We will operate as business as usual until the combination is approved by regulatory agencies and both sets of company shareholders.

I am pleased to provide insight into our prior quarter results and we will appreciate you limiting your Q&A to our results and not to the combination or transaction. Please turn to Slide 3. We are very pleased with our start to fiscal 2023. Our first quarter revenues were up 19% over the prior year period, with organic growth contributing 9.1%. We are pleased to report strong revenue growth across both segments. ISS organic revenue growth was nearly 8% and APT organic revenue growth was more than 12% year-over-year. We had strong sales across all regions and most end markets with price realization and volume both contributing to growth. FX continues to be a headwind, primarily for APT as the dollar weakened throughout the quarter from its late peak in September.

Adjusted EBITDA was up approximately 34% and margin expanded 190 basis points over the prior year quarter. We are very pleased that our LTM-adjusted EBITDA margin grew 40 basis points to 17.5%. We continue to see broad-based demand across our key end markets, particularly in life sciences and food and beverage. Our order flow remained healthy as well, with our book-to-bill ratio again over 1.0 and our pipeline remains robust. Given the first quarter performance and the order momentum, we are confident in delivering on the year’s commitments made in our Q4 earnings call. Net working capital increased in the quarter as we intentionally built inventory to support our order activity. Operating cash flow was in turn impacted, though we still expect to exceed our 100% adjusted free cash flow conversion target for the fiscal year.

We are able to reduce our net debt leverage ratio to 2.5x and our balance sheet is healthy and flexible and remains a top priority in this rising interest environment. Please turn to Slide 4. Water is essential for daily life, whether for human consumption, industrial production or commercial purposes. Manufacturers are requiring more stringent levels of ultra-pure water while wastewater reuse has become vital in protecting, diminishing water supplies and reducing the strain on municipalities. Water is becoming increasingly complex and Evoqua is an essential treatment provider making clean water more accessible. The long-term market trends are very favorable and we expect our business to be resilient through normal market cycles. This slide highlights key financial metrics that demonstrate our resilient business model driven in part by our recurring revenue streams with service and aftermarket making up approximately 60% of our revenue.

Digitally connected outsourced water, strong and growing end markets and our industry-leading service are just a few drivers for organic growth in favorable and unfavorable market conditions. As stated previously, cash flow was down for the quarter, but we continue to target adjusted free cash flow conversion of 100% and have achieved that level for several years. Our management team is focused on driving strong and consistent cash generation that is supported by our base of stable, profitable and recurring revenues. We are making strategic decisions on working capital and we will see opportunities for improvement as supply chain performance becomes consistent. Please turn to Slide 5. This chart represents our second quarter expected order activity by end market compared to the prior year second quarter.

We continue to expect strong orders across most end markets, particularly life sciences, food and beverage and aquatics. Microelectronics has been very strong in the prior year period and we expect similar results in the quarter. Microelectronics remains on a long-term upcycle, though timing on €“ timing and project schedules could create some volatility in this key end market. Overall, we expect to see stable growing order demand across most of our end markets for the remainder of fiscal 2023. And as I previously commented, our inventory investments have us well positioned to convert our backlog effectively and to achieve a higher rate of on-time customer delivery. We have seen some project delays related to permitting issues and customer schedule management, but cancellations remain immaterial.

Please turn to Slide 6. We look at our environmental impact through our own footprint on the environment, but also through the products and services we provide to our customers. We are pleased to highlight two recent handprint wins which are expected to positively impact our customers’ water conservation and reuse initiatives while generating an attractive return on investment. Our first highlight showcases the potential impact of the Infrastructure Law with an industrial chemical manufacturing partnering with a regional municipal wastewater facility in Virginia. Evoqua was selected for the pilot to design, source and assemble a wastewater treatment system that combine ultrafiltration and RO technologies in a mobile platform. The pilot will test the treatment of wastewater for recycling and providing high-quality feed water for plant use.

The goal of the pilot is to determine the potential for a full-scale system with support from the new Infrastructure Bill. A full-scale system would be designed to reduce the demand on the water treatment facility by 3,000 gallons per minute and to open additional drinking water capacity that could serve more than 14,000 homes in the region. We also helped the supermarket chain divert high-strength organic waste using our anaerobic membrane bioreactor. The biological process converts the waste into biogas that is then converted into renewable energy. This system will treat up to 230,000 tons of food waste annually, reducing the landfill burden while producing 1,400 million BTUs of biogas per day which is the average daily use of approximately 7,000 U.S. homes.

Please turn to Slide 7. While helping our customers improve their sustainability with our solutions, we are still addressing our own operations to minimize our footprint. We are very pleased to announce that we were recently selected as 1 of only 19 companies to receive The Terra Carta Seal. The Terra Carta Seal was launched at the COP26 Conference by King Charles III when he was the c. It recognizes global companies that are driving innovation and demonstrating their commitment to the creation of genuinely sustainable markets. The Terra Carta was awarded to companies with ambitions aligned with the recovery plan for nature, people and the planet, which was launched in January of 2021. We are also privileged to have ranked sixth this year on the Corporate Knights’ list of the 100 most sustainable companies in the world.

It is the second year that Evoqua has been included in the top 100 rankings and an improvement from our 19th position in 2021. We are honored to be recognized as a sustainability leader, enabling our customers to become more sustainable through our solutions and with our services. Last but not least, we received the Frost & Sullivan 2022 Global Company of the Year Award in the Water Technology category. The company was honored for our visionary innovation, market-leading performance and unmatched customer service. We thank Frost & Sullivan for recognizing us at the forefront of innovation and growth in our industry. Our team has worked tirelessly to achieve these great awards and I am thankful for their efforts and the progress that we continue to make.

I would now like to turn the call over to Ben.

Ben Stas: Thank you, Ron. Please turn to Slide 8. For the first quarter, reported revenues were up 19% to approximately $436 million. Organic revenue growth contributed approximately 9%, driven by broad-based price realization and volume growth. We saw organic revenue growth in aftermarket services and capital as well as across all regions and most product lines versus the prior year. First quarter adjusted EBITDA increased approximately 34% over the prior year period to $72.7 million for an overall margin of 16.7%. Favorable price realization, mix and higher sales volume were primary drivers of improved profitability. Adjusted EBITDA margins increased approximately 190 basis points over the prior year period. We were pleased that price/cost was positive and accretive to margins for the quarter.

Please turn to Slide 9. Our Integrated Solutions and Services segment’s first quarter revenues were up approximately 25% to $305 million. Light and General and Life Sciences saw strong growth. Organic revenues growth contributed nearly 8%, driven primarily by price realization. Service and aftermarket revenues were strong across most end markets. Our capital projects and outsourced water pipeline is strong and growing. Digitally enabled revenues were up over 20% versus the prior year quarter. Adjusted EBITDA increased approximately 29% to $69 million due to favorable price and the consolidation of Mar Cor’s operations, partly offset by material inflation and productivity. Adjusted EBITDA margin for the quarter was 22.6%, up 80 basis points from the prior year.

Please turn to Slide 10. We continue to see strong year-over-year growth in ISS backlog. First quarter backlog was up approximately $162 million or 21% on over the prior year quarter and up 3% versus Q4 of last year. Our pipeline continues to be robust with opportunities across multiple end markets. We expect to see our book-to-bill ratio remain above one in the fiscal year. Please turn to Slide 11. Applied Product Technologies first quarter revenues were approximately $130 million, up more than 7%. Organic revenue growth contributed $14.8 million or approximately 12%, driven by strong volume growth and price realization with revenue growth across all regions and most product lines. Microelectronics, especially in APAC, saw strong growth. As Ron mentioned, foreign currency translation unfavorably impacted revenues.

Adjusted EBITDA for the first quarter increased nearly 12% to approximately $25 million and adjusted EBITDA margins saw a 70 basis points improvement to 18.8%, driven by favorable price realization, higher sales volume and mix, partly offset by inflationary impacts, productivity and FX. Please turn to Slide 12. Capital spending, primarily for outsourced water orders, was approximately $23 million for the quarter or approximately 5.2% of revenues. First quarter net working capital grew to 60% of LTM sales to facilitate strong order rate growth. As previously stated, higher inventory levels and accounts receivable collection timing in the quarter, primarily drove the increase in net working capital. Specifically, we built stock for certain raw materials such as resin and membranes.

Due to limited supply and extended international shipping times, another portion of the inventory increase was work in process needed to support strong forecasted demand. We anticipate this will be utilized in the coming months as backlog is converted. We expect to reach our target of 100% plus adjusted free cash flow conversion for the fiscal year. Please turn to Slide 13. We had a strong quarter of revenues and profitability, which allowed us to build on our balance sheet health. Debt reduction remains a priority. And as Ron mentioned, our net leverage ratio is now at 2.5x just 1 year after the Mar Cor action. I would now like to turn the call back over to Ron. Ron?

Ron Keating: Thank you, Ben. Please turn to Slide 14. We had a strong quarter with outstanding results across most key financial metrics. In particular, adjusted EBITDA margin for the first quarter of 16.7% and LTM EBITDA margin of 17.5% are the highest margins we have reported since becoming a public company. Market demand remains strong, and we are pleased to deliver broad-based organic growth across both segments, all regions and most product lines. Our pipeline remains robust and our backlog continues to grow. We continue to manage with rising costs and supply chain uncertainties, and we’re pleased to once again be price/cost positive for the quarter. Customers continue to see the value of outsourced water which continues to contribute to ISS’s growth and recurring revenue model.

Digitally connected sales were again up double digits. Heading into the second quarter, we are focused on sales and operational execution to convert our strong backlog. Price realization is expected to be positive as inflation abates in some pockets and overall labor and material availability show signs of improvement as well. We continue to monitor the timing of customer purchase orders and shipment requests as supply chain and regulatory uncertainties could create timing challenges. Given our backlog and order activity, we are confident in delivering our commitments for FY €˜23. However, given the pending transaction, we are not giving official forward guidance. I will now open the call for your questions and remind you to please focus on Evoqua performance and not the outlook for the pending transaction.

See also 13 Cheap DRIP Stocks To Buy and 15 Largest Pesticide Companies in the US.

Q&A Session

Operator: Thank you. We will take our first question from Deane Dray with RBC Capital Markets.

Deane Dray: Thank you. Good morning, everyone. Congrats again on the merger agreement with Xylem.

Ron Keating: Thanks, Deane. Good morning.

Ben Stas: Thanks, Deane.

Deane Dray: If we can start with the ISS pipeline, could you just take us through what kind of rank or the end markets, where are you seeing the most interest? And could you talk about any kind of reverse inquiries that you’re getting from customers that potentially either within these verticals, but also geographically, are you getting any inbound questions from potential customers in Europe and Asia?

Ron Keating: Yes. Thanks, Deane. As you look at Slide 5, we continue just to see strength across the majority of the end markets as we’ve highlighted. Life Sciences very robust. Chemical processing continues to be very strong. And the one that we had always pointed out is the canary in the coal mine that we’d be concerned about keeping an eye on, on was light and general industry and that continues to be a street green. So we feel really good about it. I highlighted in the comments, actually, we’re seeing strong activity from power and renewables as well, and we’re certainly seeing that. So you kind of look at those markets, they are all very good. As we think about microelectronics and we show it is neutral. Last year, this quarter was just fantastic, and we anticipate it will be flat with last year.

So we’re feeling very good about the end markets that we’re seeing right now. Reverse inquiries. We’re really not hearing a lot right now, but we are hearing customers kind of come out and say, obviously, we know who you’re partnering with. The outlook for the combination is fantastic. We have got zero concerns coming out of customers. But I think if anything, it will be stronger as we start to make headway and we’re planning. Obviously, right now, we’re only in the planning phase, and we can only plan until the deal closes. And €“ but international with APT is pretty much a great opportunity out of the gate.

Deane Dray: That’s great to hear. And a follow-up for Ben on what’s the expected free cash flow conversion timing for the year? Some of this, you said there was some accounts receivable collection timing, so that would suggest more near-term conversion, but just kind of the pace of free cash flow conversion for the year.

Ben Stas: Yes. We expect to continue to improve as we go through the year. In Q4, $10 to be our strongest free cash conversion quarter, Deane. but we took the opportunity looking at our demand and looking at our outlook to make sure we secure the ability to meet that demand and secured some of the areas, in particular, for the service organization like resins and membranes to make sure we had the stock. And then APT on their end, they certainly are building the work in process to be delivered on that €“ on the shipments that are coming. So we naturally expect free cash flow to improve as we head through the year. And then as you know, we’re €“ at September year-end, and the calendar year-end, you typically see companies that at times, particularly with uncertain times hold on payables a bit, and we did see some of that in December, but receivables are looking fine as we go and we expect them to continue to look fine collection.

Deane Dray: That sounds great to hear. Thank you.

Ron Keating: Thanks.

Operator: Thank you. Our next question comes from Nathan Jones of Stifel. Speak.

Nathan Jones: Good morning, everyone.

Ron Keating: Good morning, Nathan.

Ben Stas: Good morning, Nathan.

Nathan Jones: I’m going to start with a bit of a follow-up to Deane’s second question now on free cash flow and maybe a bit more on the inventory build. I think you guys have been expecting kind of a higher mix of capital versus outsourced kind of projects relatively speaking in €˜23. Some of these inventory build related to what are more near-term deliveries on those capital kinds of projects. And with this in the plan when we were coming into 2023, this building inventory or has it been because you’re seeing better orders on the capital burn?

Ben Stas: We are seeing strong orders on the capital front. Across the board, we’re seeing strong orders than we anticipated. And so as we saw those orders coming in as we went through the quarter, we decided €“ and the activity order rates, we decided to make sure that we secured our stock to make sure we can be on those orders.

Nathan Jones: That’s helpful. Go ahead.

Ben Stas: So from a plan perspective, obviously, it’s €“ things are developing stronger than planned. And we definitely want to €“ the good thing about this business is we have visibility and it gives us time to respond. So obviously, we’re responding accordingly.

Nathan Jones: Thanks for that. My second question was around a comment you made in your prepared remarks that price/cost was actually positive to margins in the quarter. Can you provide a bit more color around that and what the expectation is for price/cost maybe as we move through the year? Do you expect it to actually be positive to margins rather than just dollar positive?

Ben Stas: So certainly, cannot provide a lot of outlook. But I will tell you, we had $9 million positive on price/cost in the course. It was strong. And we did the math. It was certainly a nice healthy part of that margin expansion. The wildcard there is always what happens to inflationary impacts. But holistically, we seem to be seeing things so down and we are certainly seeing the benefits of the price realization actions that we have been taking.